WS #15033

Geopolitical tensions in the Middle East have escalated sharply following the US rejection of an Iranian ceasefire proposal, driving Brent crude toward the $100 mark. Iran is now demanding a US response on Hormuz Strait fees by September 30, creating an imminent supply shock risk. This escalation is corroborated by Trump's denial of sanctions relief offers and ongoing diplomatic friction between the US, Saudi Arabia, and Iran. While the RBA's rate hike to a 15-year high adds macro pressure, the oil supply threat is the dominant market-moving force, pressuring energy beneficiaries while hurting airlines and consumer discretionary. In the technology sector, AMD's $8.2B acquisition of World Labs signals an aggressive push into spatial computing and AI-driven 3D assets, positioning it to compete directly with Apple's ecosystem. Simultaneously, Nvidia is launching an AI safety 'kill switch' to manage rogue agents, a development that reinforces its infrastructure moat but highlights growing regulatory and safety concerns. The Anthropic IPO prospectus continues to weigh on the AI narrative, revealing massive $42B losses and $7.3B in compute costs, which complicates the valuation thesis for the broader AI sector despite the ongoing build-out. Emerging themes include a bifurcation in the GLP-1 market, with Lilly's new Foundayo data beating oral semaglutide, and Hengrui Pharma's $2.6B deal with Novo Nordisk for a once-weekly oral GLP-1/GIP agonist, intensifying competition in the obesity space. Meanwhile, Florida's injunction attempt against OpenAI introduces a new regulatory risk vector for generative AI, potentially slowing deployment timelines. The RBA's hawkish move suggests global central banks are not yet done hiking, adding a headwind to rate-sensitive growth stocks.